S100A8 and rheumatoid arthritis: S100A8/A9 (calprotectin) has been reportedly recognized as a sensitive biomarker for inflammatory diseases, such as rheumatoid arthritis, psoriasis, and vasculitis (Benoit et al., 2006; Pepper et al., 2013; Nordal et al., 2016).